Teva Ends Class Suit With $1.3M Deal To Publicize Execs' Pay
Teva Pharmaceutical Industries Ltd. on Wednesday agreed to settle an Israeli class action for $1.3 million, in addition to publishing its senior executives' pay in subsequent regulatory filings....To view the full article, register now.
Already a subscriber? Click here to view full article